Literature DB >> 9021189

Use of a fluorescent probe to assess the activities of candidate agents against intracellular forms of Encephalitozoon microsporidia.

G J Leitch1, M Scanlon, A Shaw, G S Visvesvara, S Wallace.   

Abstract

Microsporidia are obligate intracellular protozoan parasites. Three species of the genus Encephalitozoon are among the microsporidia that infect immunodeficient humans. These species, Encephalitozoon cuniculi, Encephalitozoon hellem, and Encephalitozoon intestinalis, all develop in a parasitophorous vacuole within a host cell. The present study describes a method that uses the fluorescent probe calcein and confocal microscopy to detect drug-induced effects in Encephalitozoon-infected green monkey kidney cells. The effects were as follows: (i) changes in parasite organization within the parasitophorous vacuole; (ii) swelling and gross morphological changes of parasite developing stages in situ; (iii) killing of developing parasite stages in situ, detected by their uptake of the fluorescent probe; and (iv) reduction in the viability of the host cell population, assessed by the loss of the probe. Verapamil and itraconazole were used to increase the vital dye loading by both uninfected and infected cells. Agents with known antimicrosporidial activity, albendazole and fumagillin, caused all three types of parasite changes at concentrations that had no detectable effect on host cell viability. The effective doses of albendazole and fumagillin that caused swelling and disorganization of parasite developing stages were 5 x 10(-7) and 10(-6) M respectively. Killing of developing stages was detected at 10-fold-higher concentrations for these agents and at 10(-5) M for metronidazole. This method can be used to screen candidate antimicrosporidial agents in infected cultured cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9021189      PMCID: PMC163711     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  29 in total

1.  Inhibition of microsporidian spore germination.

Authors:  G J Leitch; G S Visvesvara; Q He
Journal:  Parasitol Today       Date:  1993-11

2.  Clinical significance of small-intestinal microsporidiosis in HIV-1-infected individuals.

Authors:  J K Eeftinck Schattenkerk; T van Gool; R J van Ketel; J F Bartelsman; C L Kuiken; W J Terpstra; P Reiss
Journal:  Lancet       Date:  1991-04-13       Impact factor: 79.321

3.  Polymerase chain reaction and culture confirmation of disseminated Encephalitozoon cuniculi in a patient with AIDS: successful therapy with albendazole.

Authors:  M A De Groote; G Visvesvara; M L Wilson; N J Pieniazek; S B Slemenda; A J daSilva; G J Leitch; R T Bryan; R Reves
Journal:  J Infect Dis       Date:  1995-05       Impact factor: 5.226

4.  Experimental microsporidiosis in immunocompetent and immunodeficient mice and monkeys.

Authors:  E S Didier; P W Varner; P J Didier; A M Aldras; N J Millichamp; M Murphey-Corb; R Bohm; J A Shadduck
Journal:  Folia Parasitol (Praha)       Date:  1994       Impact factor: 2.122

5.  Disseminated microsporidiosis due to Septata intestinalis in nine patients infected with the human immunodeficiency virus: response to therapy with albendazole.

Authors:  G J Dore; D J Marriott; M C Hing; J L Harkness; A S Field
Journal:  Clin Infect Dis       Date:  1995-07       Impact factor: 9.079

6.  In vitro model to assess effect of antimicrobial agents on Encephalitozoon cuniculi.

Authors:  B Beauvais; C Sarfati; S Challier; F Derouin
Journal:  Antimicrob Agents Chemother       Date:  1994-10       Impact factor: 5.191

7.  Reversal effect of itraconazole on adriamycin and etoposide resistance in human leukemia cells.

Authors:  M Kurosawa; M Okabe; N Hara; K Kawamura; S Suzuki; K Sakurada; M Asaka
Journal:  Ann Hematol       Date:  1996-01       Impact factor: 3.673

8.  Effect of fumagillin on in vitro multiplication of Encephalitozoon cuniculi.

Authors:  J A Shadduck
Journal:  J Protozool       Date:  1980-05

9.  The microsporidian spore invasion tube. IV. Discharge activation begins with pH-triggered Ca2+ influx.

Authors:  J Pleshinger; E Weidner
Journal:  J Cell Biol       Date:  1985-06       Impact factor: 10.539

10.  Macrophages possess probenecid-inhibitable organic anion transporters that remove fluorescent dyes from the cytoplasmic matrix.

Authors:  T H Steinberg; A S Newman; J A Swanson; S C Silverstein
Journal:  J Cell Biol       Date:  1987-12       Impact factor: 10.539

View more
  6 in total

1.  In vitro susceptibilities of the microsporidia Encephalitozoon cuniculi, Encephalitozoon hellem, and Encephalitozoon intestinalis to albendazole and its sulfoxide and sulfone metabolites.

Authors:  O Ridoux; M Drancourt
Journal:  Antimicrob Agents Chemother       Date:  1998-12       Impact factor: 5.191

2.  A spore counting method and cell culture model for chlorine disinfection studies of Encephalitozoon syn. Septata intestinalis.

Authors:  D M Wolk; C H Johnson; E W Rice; M M Marshall; K F Grahn; C B Plummer; C R Sterling
Journal:  Appl Environ Microbiol       Date:  2000-04       Impact factor: 4.792

Review 3.  Molecular techniques for detection, species differentiation, and phylogenetic analysis of microsporidia.

Authors:  C Franzen; A Müller
Journal:  Clin Microbiol Rev       Date:  1999-04       Impact factor: 26.132

4.  Role of P glycoprotein in the course and treatment of Encephalitozoon microsporidiosis.

Authors:  G J Leitch; M Scanlon; A Shaw; G S Visvesvara
Journal:  Antimicrob Agents Chemother       Date:  2001-01       Impact factor: 5.191

5.  Purification of Encephalitozoon cultures contaminated by mycoplasmas by murine intraperitoneal inoculation.

Authors:  O Ridoux; C Foucault; M Drancourt
Journal:  J Clin Microbiol       Date:  1998-08       Impact factor: 5.948

Review 6.  Role of gap junctions and hemichannels in parasitic infections.

Authors:  José Luis Vega; Mario Subiabre; Felipe Figueroa; Kurt Alex Schalper; Luis Osorio; Jorge González; Juan Carlos Sáez
Journal:  Biomed Res Int       Date:  2013-10-23       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.